There Is Only 1 GLP-1 Stock to Buy In 2025
Weighing the Options The introduction of Novo Nordisk’s (NYSE:NVO | NVO Price Prediction) Ozempic revolutionized the fight against obesity, shifting the narrative from lifestyle interventions to pharmacological solutions. Glucagon-like peptide-1 (GLP-1) receptor…